Can your Child's genes guide safer cancer drugs?
NCT ID NCT06744712
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 36 times
Summary
This study looks at 130 children with cancer to find genetic differences that affect how their bodies process chemotherapy and supportive medicines. By testing a panel of genes, researchers hope to learn how often these differences occur and whether they can help tailor drug choices or doses. The goal is to reduce side effects and improve treatment, but this study is only gathering information, not testing a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Levine Childrens Hospital Pediatric Cancer and Blood Disorders
Charlotte, North Carolina, 28203, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.